FDA NDC Directory · JSON-LD · Markdown

KYMRIAH

NDC 0078-0846 · CELLULAR THERAPY · INJECTION, SUSPENSION

Generic nametisagenlecleucel
Labeler / ManufacturerNovartis Pharmaceuticals Corporation
Marketing categoryBiologic License Application · App BLA125646
Dosage form / routeINJECTION, SUSPENSION · INTRAVENOUS
Active ingredientsTISAGENLECLEUCEL (2000000 1/1)
Marketing started20170830
Package count1

External sources

Source: openFDA. Public-domain (CC0).